Eva Schrezenmeier

9PUBLICATIONS
34CO-AUTHORS
Molecular medicineAutoimmunityCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 11, 2024
Letermovir Rescue Therapy in Kidney Transplant Recipients with Refractory/Resistant CMV Disease.

Ellen von Hoerschelmann, Johannes Münch, Linde Gao

|May 04, 2022
Plasmablast-like Phenotype Among Antigen-Experienced CXCR5-CD19low B Cells in Systemic Lupus Erythematosus.

Franziska Szelinski, Ana Luisa Stefanski, Eva Schrezenmeier

|Dec 28, 2021
B Cell Numbers Predict Humoral and Cellular Response Upon SARS-CoV-2 Vaccination Among Patients Treated With Rituximab.

Ana-Luisa Stefanski, Hector Rincon-Arevalo, Eva Schrezenmeier

|Jun 16, 2021
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients.

Hector Rincon-Arevalo, Mira Choi, Ana-Luisa Stefanski

|Feb 02, 2021
What happens after graft loss? A large, long-term, single-center observation.

Eva Schrezenmeier, Lukas J Lehner, Marina Merkel

Pageof 2